2/10
01:00 pm
phio
Phio Pharmaceuticals (NASDAQ:PHIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
High
Report
Phio Pharmaceuticals (NASDAQ:PHIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
1/26
08:26 am
phio
Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference [Yahoo! Finance]
Medium
Report
Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference [Yahoo! Finance]
11/17
09:11 am
phio
Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress [Yahoo! Finance]
Low
Report
Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress [Yahoo! Finance]